Skip to main content

Boundless Bio, Inc.

Qualité des données : 83%
BOLD
Nasdaq Manufacturing Chemicals
1,13 €
▼ 0,01 € (-0,88%)
Cap. Boursière: 25,66 M
Prix
1,15 €
Cap. Boursière
25,66 M
Fourchette du Jour
Fourchette 52 Semaines
Volume
Ouverture —
Moyenne 50J / 200J
Moyenne 50J / 200J

Quick Summary

Points Clés

Negative free cash flow of -47,21 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-49,98%
Au-dessus de la moyenne du secteur (-53,34%)
ROIC-30,70%
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio10,14
Interest CoverageN/A

Valorisation

PE (TTM)
-0,44
Au-dessus de la moyenne du secteur (-1,47)
P/B Ratio0,23
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -0,4 -1,5
P/B 0,2 1,6
ROE % -50,0 -53,3
Net Margin % -41,5
Rev Growth 5Y % 1,8
D/E 0,3

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -58,20 M
ROE -49,98% ROA -33,43%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -47,21 M
ROIC -30,70% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 10,14
Interest Coverage N/A Asset Turnover N/A
Working Capital 108,31 M Tangible Book Value 110,17 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,44 Forward P/E N/A
P/B Ratio 0,23 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -184,00%
Market Cap 25,66 M Enterprise Value 10,68 M
Per Share
EPS (Diluted TTM) -2,60 Revenue / Share N/A
FCF / Share -2,11 OCF / Share -2,08
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 81,12%
SBC-Adj. FCF -53,33 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue
Net Income -58,20 M -65,36 M
EPS (Diluted) -2,60 -3,85
Gross Profit
Operating Income -63,55 M -73,27 M
EBITDA
R&D Expenses 44,85 M 55,27 M
SG&A Expenses
D&A 1,25 M 1,09 M
Interest Expense
Income Tax 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 157,06 M 206,41 M
Total Liabilities 58,41 M 55,77 M
Shareholders' Equity 98,65 M 150,64 M
Total Debt
Cash & Equivalents 17,87 M 26,59 M
Current Assets 109,61 M 154,39 M
Current Liabilities 12,54 M 8,14 M